Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils.

Omeprazole reduced the effects of IL-13 in both the epithelial air-liquid interface model and eosinophil-epithelial co-cultures, reducing barrier dysfunction, chemokine expression, and upregulation of eosinophil adhesion markers.